Date: Monday, October 10, 2011 Time: 9:00 a.m. (PST)
Speaker: Darryl Gietzen, Ph.D., Field Application Scientist, Ingenuity Systems
IPA was used to interpret Alzheimer’s disease biology by comparing Illumina RNA-Seq data from Alzheimer’s disease (AD) and normal brain samples. This analysis revealed very specific biological changes in certain classes of transcript expression, demonstrating how the unique benefits of RNA-Seq can help characterize disease changes.
In this webinar, we will discuss how:
- IPA maximizes RNA-Seq data analysis
- Grouping and analyzing all significantly changed genes in RNA-Seq data can provide pathway level information
- The sensitivity and accuracy of RNA-Seq enables pathway analysis on a subset of genes to elucidate more subtle biological changes